$WOOF
Petco Health & Wellness Company, Inc.

2022 Q2 Form 10-Q Financial Statement

#000156459022022811 Filed on June 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q2
Revenue $1.476B $1.514B $1.415B
YoY Change 4.31% 13.21% 27.07%
Cost Of Revenue $868.3M $878.9M $818.0M
YoY Change 6.15% 14.37% 26.38%
Gross Profit $607.7M $635.5M $597.0M
YoY Change 1.79% 11.63% 28.03%
Gross Profit Margin 41.17% 41.97% 42.19%
Selling, General & Admin $557.7M $552.6M $549.2M
YoY Change 1.55% 10.72% 22.07%
% of Gross Profit 91.78% 86.95% 92.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $46.97M $46.79M $41.61M
YoY Change 12.88% 2.17% -4.5%
% of Gross Profit 7.73% 7.36% 6.97%
Operating Expenses $557.7M $552.6M $549.2M
YoY Change 1.55% 10.68% 22.07%
Operating Profit $49.94M $82.91M $47.75M
YoY Change 4.59% 18.44% 191.78%
Interest Expense $19.63M -$18.88M $20.53M
YoY Change -4.36% -62.0% -66.24%
% of Operating Profit 39.32% -22.78% 42.99%
Other Income/Expense, Net $314.0K -$30.44M $0.00
YoY Change
Pretax Income $30.64M $33.58M $6.403M
YoY Change 378.51% -16892.0% -114.47%
Income Tax $10.00M $9.689M $2.679M
% Of Pretax Income 32.64% 28.85% 41.84%
Net Earnings $24.69M $28.99M $7.560M
YoY Change 226.63% -567.65% -124.26%
Net Earnings / Revenue 1.67% 1.91% 0.53%
Basic Earnings Per Share $0.09 $0.03
Diluted Earnings Per Share $0.09 $109.1K $0.03
COMMON SHARES
Basic Shares Outstanding 265.1M 264.2M
Diluted Shares Outstanding 265.7M 265.0M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $190.9M $211.6M $174.0M
YoY Change 9.71% 89.95%
Cash & Equivalents $190.9M $211.6M $174.0M
Short-Term Investments
Other Short-Term Assets $133.7M $86.09M $42.36M
YoY Change 215.74% 88.74%
Inventory $682.0M $675.1M $574.7M
Prepaid Expenses $42.36M $46.72M
Receivables $42.22M $55.62M $38.08M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.049B $1.071B $875.9M
YoY Change 19.75% 37.71%
LONG-TERM ASSETS
Property, Plant & Equipment $2.092B $726.9M $639.4M
YoY Change 227.21% 15.84%
Goodwill $2.184B $2.179B
YoY Change 0.21%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $155.7M $152.8M $142.3M
YoY Change 9.37% 10.56%
Total Long-Term Assets $5.457B $5.427B $5.318B
YoY Change 2.62% 2.44%
TOTAL ASSETS
Total Short-Term Assets $1.049B $1.071B $875.9M
Total Long-Term Assets $5.457B $5.427B $5.318B
Total Assets $6.506B $6.498B $6.193B
YoY Change 5.04% 6.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $392.7M $404.0M $352.4M
YoY Change 11.42% 19.0%
Accrued Expenses $213.4M $210.9M $218.9M
YoY Change -2.53% 44.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $21.79M $21.76M $20.20M
YoY Change 7.87% 889.27%
Total Short-Term Liabilities $1.012B $1.053B $995.2M
YoY Change 1.67% 20.32%
LONG-TERM LIABILITIES
Long-Term Debt $1.637B $1.640B $1.650B
YoY Change -0.74% -0.36%
Other Long-Term Liabilities $132.0M $134.1M $138.1M
YoY Change -4.39% -0.19%
Total Long-Term Liabilities $1.769B $1.774B $1.788B
YoY Change -1.02% -0.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.012B $1.053B $995.2M
Total Long-Term Liabilities $1.769B $1.774B $1.788B
Total Liabilities $4.218B $4.242B $4.121B
YoY Change 2.35% 5.51%
SHAREHOLDERS EQUITY
Retained Earnings $166.9M $142.2M -$14.69M
YoY Change -1235.79% -738.92%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.307B $2.274B $2.087B
YoY Change
Total Liabilities & Shareholders Equity $6.506B $6.498B $6.193B
YoY Change 5.04% 6.95%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q2
OPERATING ACTIVITIES
Net Income $24.69M $28.99M $7.560M
YoY Change 226.63% -567.65% -124.26%
Depreciation, Depletion And Amortization $46.97M $46.79M $41.61M
YoY Change 12.88% 2.17% -4.5%
Cash From Operating Activities $57.52M $69.77M $115.0M
YoY Change -49.98% 3.98% -456.16%
INVESTING ACTIVITIES
Capital Expenditures $65.91M -$74.78M $47.35M
YoY Change 39.19% 18.14% 69.75%
Acquisitions
YoY Change
Other Investing Activities $5.467M
YoY Change 173.35%
Cash From Investing Activities -$65.91M -$69.31M -$47.35M
YoY Change 39.19% 13.07% 69.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $4.250M $1.678B
YoY Change -99.75% 1079.17%
Cash From Financing Activities -15.26M -3.919M -7.213M
YoY Change 111.56% -95.9% -102.84%
NET CHANGE
Cash From Operating Activities 57.52M 69.77M 115.0M
Cash From Investing Activities -65.91M -69.31M -47.35M
Cash From Financing Activities -15.26M -3.919M -7.213M
Net Change In Cash -8.391M -3.461M 60.44M
YoY Change -113.88% -96.14% -68.78%
FREE CASH FLOW
Cash From Operating Activities $57.52M $69.77M $115.0M
Capital Expenditures $65.91M -$74.78M $47.35M
Free Cash Flow -$8.391M $144.6M $67.65M
YoY Change -112.4% 10.85% -212.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsCurrent
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsCurrent
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
931000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000.0
CY2022Q2 us-gaap Gross Profit
GrossProfit
607674000
CY2021Q2 us-gaap Gross Profit
GrossProfit
596985000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Minority Interest
MinorityInterest
-18195000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
557735000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
549236000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
49939000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2255819000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6497941000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
868317000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
47749000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
20000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
21000
CY2022Q2 us-gaap Interest Expense
InterestExpense
19634000
CY2021Q2 us-gaap Interest Expense
InterestExpense
20529000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20838000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
314000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
30639000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6403000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2679000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3163000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2425000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
23802000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
6149000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-891000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1411000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
24693000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7560000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
265050000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
264215000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
265701000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
265028000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
6149000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1598000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-786000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1598000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-786000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
22204000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5363000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-891000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1411000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23095000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6774000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2255819000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12055000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
23802000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1598000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-2371000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2287707000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2055265000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11604000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-786000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2072232000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
23802000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
6149000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46967000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41607000
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1224000
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2165000
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4832000
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1708000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
12222000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
11604000
CY2022Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
162000
CY2021Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
947000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20838000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3163000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2425000
CY2022Q2 woof Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
105249000
CY2021Q2 woof Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
105188000
CY2022Q2 woof Other Nonoperating Income Expenses
OtherNonoperatingIncomeExpenses
314000
CY2021Q2 woof Other Nonoperating Income Expenses
OtherNonoperatingIncomeExpenses
0
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13397000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3748000
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6930000
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36008000
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9896000
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9140000
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11314000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20119000
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-16478000
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2483000
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
11290000
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
66120000
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-112272000
CY2021Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-116994000
CY2022Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1259000
CY2021Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1859000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57519000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
115002000
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
65910000
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47351000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65910000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47351000
CY2022Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2021Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1700000000
CY2022Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4250000
CY2021Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1678111000
CY2022Q2 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
0
CY2021Q2 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
24665000
CY2022Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1022000
CY2021Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
593000
CY2022Q2 woof Proceeds From Employee Stock Purchase Plan And Stock Option Exercises
ProceedsFromEmployeeStockPurchasePlanAndStockOptionExercises
1453000
CY2021Q2 woof Proceeds From Employee Stock Purchase Plan And Stock Option Exercises
ProceedsFromEmployeeStockPurchasePlanAndStockOptionExercises
0
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11441000
CY2021Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2022Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. These estimates are based on information that is currently available and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could vary from those estimates under different assumptions or conditions.  </p>
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190893000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
211602000
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
7346000
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
10288000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
198239000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
221890000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1475991000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1414994000
CY2022Q2 us-gaap Line Of Credit Facility Covenant Compliance
LineOfCreditFacilityCovenantCompliance
the Company was in compliance with its covenants under the First Lien Term Loan and the ABL Revolving Credit Facility.
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
150000000.0
CY2022Q2 woof Maximum Borrowing Capacity Of Eligible Accounts Receivable In Percentage
MaximumBorrowingCapacityOfEligibleAccountsReceivableInPercentage
0.90
CY2022Q2 woof Borrowing Capacity Of Net Orderly Liquidation Value Of Eligible Inventory In Percentage
BorrowingCapacityOfNetOrderlyLiquidationValueOfEligibleInventoryInPercentage
0.90
CY2022Q2 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
50000000.0
CY2022Q2 woof Consideration Recognized Under Collaboration Agreement
ConsiderationRecognizedUnderCollaborationAgreement
0
CY2022Q2 woof Impairment Of Fixed Asset And Right Of Use Asset
ImpairmentOfFixedAssetAndRightOfUseAsset
900000
CY2021Q2 woof Impairment Of Fixed Asset And Right Of Use Asset
ImpairmentOfFixedAssetAndRightOfUseAsset
1100000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12222000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11604000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3300000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3600000

Files In Submission

Name View Source Status
0001564590-22-022811-index-headers.html Edgar Link pending
0001564590-22-022811-index.html Edgar Link pending
0001564590-22-022811.txt Edgar Link pending
0001564590-22-022811-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g4qnx3qrfo0x000001.jpg Edgar Link pending
g4qnx3qrfo0x000002.jpg Edgar Link pending
g4qnx3qrfo0x000003.jpg Edgar Link pending
gbecglefwnpq000001.jpg Edgar Link pending
gbecglefwnpq000002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
woof-10q_20220430.htm Edgar Link pending
woof-10q_20220430_htm.xml Edgar Link completed
woof-20220430.xsd Edgar Link pending
woof-20220430_cal.xml Edgar Link unprocessable
woof-20220430_def.xml Edgar Link unprocessable
woof-20220430_lab.xml Edgar Link unprocessable
woof-20220430_pre.xml Edgar Link unprocessable
woof-ex101_66.htm Edgar Link pending
woof-ex102_65.htm Edgar Link pending
woof-ex103_96.htm Edgar Link pending
woof-ex104_95.htm Edgar Link pending
woof-ex105_63.htm Edgar Link pending
woof-ex311_9.htm Edgar Link pending
woof-ex312_6.htm Edgar Link pending
woof-ex321_7.htm Edgar Link pending
woof-ex322_8.htm Edgar Link pending